Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-09-01 16:05:10 ET · period of report 2026-08-31 · accession 0001468316-26-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-01 16:05 | 2026-08-31 | FENC | Raykov Rosty | Former Dir | A - Grant | $0.00 | +2,778 | 134.4K | +2% | $0 |
| T | 2026-09-01 16:05 | 2026-09-01 | FENC | Raykov Rosty | Former Dir | S - Sale | $12.11 | -10.0K | 124.4K | -7% | -$121.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-08-31 | A | A | 2,778 | $0.00 | 134,411 | D | — | — | (F1) Represents shares released from restriction from shares awarded 5/16/2024. |
| 2 | Common | Common shares | 2026-09-01 | S | D | 10,000 | $12.11 | 124,411 | D | — | — | (F2) Represents shares sold pursuant to a 10b5-1 plan dated September 19, 2025. |